InflaRx
Price & Volume
Stats
See more52W Range | $0.71-$1.94 |
Market Cap | $69.1M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $29,331 |
Revenue Growth (YoY) | -80.8% |
Gross Profit (12 Mos) | -$7.2M |
Diluted EPS | -$0.79 |
News
See moreYahoo Finance • 9 days ago
InflaRx Announces Late-Breaker Oral Presentation on Vilobelimab Phase 3 Results in Pyoderma Gangrenosum at 2026 American Academy of Dermatology Annual Meeting
Yahoo Finance • 13 days ago
InflaRx receives Nasdaq notification
Yahoo Finance • 13 days ago
InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
Yahoo Finance • 3 months ago
InflaRx Announces International Nonproprietary Name of “Izicopan” for INF904
About
CEO | Prof. Niels C. Riedemann M.D., Ph.D. |
Address | Winzerlaer Str. 2, Jena, Germany, 07745 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 74 |
